Connor, Clark & Lunn Investment Management has reduced its short position in the medical technology company Bonesupport to below 0.5 percent and is therefore no longer a public short seller.
There are five public short sellers in the company. In total, 9.98 percent of the company’s capital is shorted. The Swedish Financial Supervisory Authority requires positions above 0.1 percent to be reported, and short positions above 0.5 percent to be made public.
